Your browser doesn't support javascript.
loading
Quality control methods and requirements for recombinant human lymphocyte function associated antigen 3 IgG1 fusion protein (rhLFA3-IgG1) / 药学学报
Acta Pharmaceutica Sinica ; (12): 762-767, 2007.
Article de Zh | WPRIM | ID: wpr-268582
Bibliothèque responsable: WPRO
ABSTRACT
To establish methods and requirements for quality control of rhLFA3-IgG1, biological potency of rhLFA3-IgG1 was determined by CD2 molecule competitive binding assay on Jurkat cell surface. Purity of rhLFA3-IgG1 was analyzed by SEC-HPLC and IEC-HPLC. Peptide mapping was preformed by tryptic digestion and RP-HPLC after sample reduced and carboxymethylation by DTT and indoacetic acid, respectively. CHO host cell protein and Protein A residual were detected by ELISA separately. The quality control methods and requirements, such as biological potency, the physical-chemical characteristic of rhLFA3-IgG1 had been established. The methods and requirements for quality control of rhLFA3-IgG1 showed advantages of assuring the products safety and efficacy, which can be used for routine quality control of rhLFA3-IgG1.
Sujet(s)
Texte intégral: 1 Indice: WPRIM Sujet Principal: Contrôle de qualité / Fixation compétitive / Biotechnologie / Cartographie peptidique / Protéines de fusion recombinantes / Immunoglobuline G / Chimie / Chromatographie en phase liquide à haute performance / Antigènes CD2 / Antigènes CD58 Limites du sujet: Humans langue: Zh Texte intégral: Acta Pharmaceutica Sinica Année: 2007 Type: Article
Texte intégral: 1 Indice: WPRIM Sujet Principal: Contrôle de qualité / Fixation compétitive / Biotechnologie / Cartographie peptidique / Protéines de fusion recombinantes / Immunoglobuline G / Chimie / Chromatographie en phase liquide à haute performance / Antigènes CD2 / Antigènes CD58 Limites du sujet: Humans langue: Zh Texte intégral: Acta Pharmaceutica Sinica Année: 2007 Type: Article